Pinned Tweet
As a cancer surgeon, thrilled to have #HPVvacine to prevent head and neck cancer, save lives and reduce suffering! Advocate & educate #cancerprevention #ILookLikeASurgeon @UCCancerCenter @UChicagoOHNS – at Chicago, IL
Gardasil #HPVvaccine FDA approved to prevent head-and-neck cancer caused by HPV! Important step to more actively advocate for all #cancerprevention #cervicalcancer #gyncsm @ACS_Illinois @UCCancerCenter @IamCervivor @equalhope_il @EAB_ENT @UChicagoOHNS statnews.com/2020/06/12/fda-…
Congratulations to all who matched today!!! So exciting to be a part of the training for tomorrow’s otolaryngologists❤️
We’re thrilled with our match! Welcome to the @UChicagoMed family Murrie, Rose, and Mary!! 👏🏻🤩 #MatchDay #OtoMatch #ENT #Residency
Elizabeth Blair retweeted
🧐Our DEPEND trial is out! Neoadjuvant nivo/chemo followed by response-stratified CRT in HPV-negative stage IVa/b HNSCC. @UCCancerCenter @UChicagoHemOnc @ajuloorimd @lab_pearson @HNCancerDoc @EIzumchenko @eevokes jamanetwork.com/journals/jam…
Elizabeth Blair retweeted
Consider us if you’re voting in the @usnews “Best Hospitals Survey!” Thanks for your support 👏🏻 @UChicagoMed @uchicagosurgery
Elizabeth Blair retweeted
The Women in Head and Neck Surgery Service is now accepting nominations for the Margaret F. Butler Outstanding Mentor of Women in Head and Neck Surgery Award! Recognize a colleague who leads in promoting gender diversity in our field. #BeLikeButler #AHNS
ow.ly/chia50TN3B1
Elizabeth Blair retweeted
Great turn out from @uchicagosurgery at the 2024 @WomenSurgeons gala! Congratulations to Dr @JBMatthews on winning the Past Presidents' Honorary Member Award! What a great evening! #ACSCC24 @AmCollSurgeons
We are fortunate to have @mcwhmd, a colleague and a leader who always has our best interests in all that she does. Congratulations and thank you for your service!!! @WomenSurgeons @uchicagosurgery
Elizabeth Blair retweeted
Good morning @AAOHNS #OTOMTG24! Get ready for “Stump the Head and Neck Experts” session at 11 AM in room 208 with Dr Neal Futran, @EAB_ENT, Raymond Chai, Rod Rezaee, Kattie Fedder and myself. Bring your toughest cases and we will bring ours! #endcancer
Elizabeth Blair retweeted
📢 Calling all #Otolaryngology students & pros! Don't miss Earl Harley, MD, at the Harry Barnes Medical Society Student Forum 🗓️ Sept 29, 2024, at #AAOHNS2024 in Miami. 🌴 Learn from a leader in pediatric ENT.
Elizabeth Blair retweeted
The @AmCollSurgeons released Surgical Ergonomics Recommendations that apply directly to OR setups. Let this serve as a reminder to everyone that ergonomics matter, no matter the job! Poor body positioning can lead to musculoskeletal disorders and many other health issues. Read the full recs here: tinyurl.com/surgeryergonomic…
Elizabeth Blair retweeted
We hate to see you go! This past week we said goodbye to our graduating externs Estrella, Tara, and Sammie. This past year getting to know you and watch you grow as clinicians has been amazing. We can’t wait to see what you’re able to accomplish!!
#audiology #aud2b #doctor
Elizabeth Blair retweeted
U.S. News & World Report's Best Hospitals list ranked University of Chicago Medical Center's Cancer and ENT programs highest in Illinois. Additionally, UCMC is one of only 25 hospitals nationwide to have at least 10 ranked specialties. uchicagomedicine.org/forefro…
Elizabeth Blair retweeted
Dr Nick Oberhelman PGY2 provided a great review on #caustic ingestions for todays #ENT #GrandRounds #MedTwitter #IamOto
Elizabeth Blair retweeted
🔥 Hot off the press: @AriRosenbergMD and colleagues just published OPTIMA II trial results in @JAMAOnc demonstrating improved functional outcomes in #HPV+OPC pts with neoadjuvant #ImmunoAndChemotherapy followed by response-adapted LRT. @UCCancerCenter
ow.ly/Xmqu50Sb99b
Elizabeth Blair retweeted
Replying to @AriRosenbergMD
@AriRosenbergMD #OPTIMA2 HNSCC DE-ESCALATION study out today @JAMAOnc:
🧑🤝🧑Broad inclusion N2 to N3 and/or T3 to T4 HPV+
🙌Excellent OS
💪Chemo/IO induction has high pathCR rates
👄Super-low g-tube rates for max de-escalated pts (green KM curve line)
see: ow.ly/Xmqu50Sb99b
Excited that our OPTIMA II trial is out in @JAMAOnc! Neoadjuvant nivo/chemo -> response-adaptive treatment for HPV+ oropharyngeal cancer @eevokes @lab_pearson @ajuloorimd @HNCancerDoc @EAB_ENT @SysmexInostics @UCCancerCenter @UChicagoMed @UChicagoHemOnc
jamanetwork.com/journals/jam…
Elizabeth Blair retweeted
Excited that our OPTIMA II trial is out in @JAMAOnc! Neoadjuvant nivo/chemo -> response-adaptive treatment for HPV+ oropharyngeal cancer @eevokes @lab_pearson @ajuloorimd @HNCancerDoc @EAB_ENT @SysmexInostics @UCCancerCenter @UChicagoMed @UChicagoHemOnc
jamanetwork.com/journals/jam…
Elizabeth Blair retweeted
Aditya Jullori, MD chairs a Clinical Science Symposium Session - “Making the Cut: Decision Support Tools in Surgically Treated HPV+ Oropharyngeal Cancer.” #ASCO24
@ajuloorimd @UChicagoRadonc @UChicagoOHNS @UCCancerCenter @UChicagoHemOnc
Elizabeth Blair retweeted
Ari Rosenberg, MD discusses the clinical studies testing the efficacy and safety profile of novel and emerging therapies using #BispecificAntibodies, #FusionProteins, and #MultikinaseInhibitors.
@AriRosenbergMD @UChicagoOHNS @UCCancerCenter @UChicagoHemOnc
Elizabeth Blair retweeted
Replying to @AriRosenbergMD
@AriRosenbergMD describing our future anti-cancer weapons portfolio in the fight against #hncsm at today's #ASCO24 education session.











































